Movement to Molecular Diagnostics for Infectious Disease

Operating room with monitor

Published:

Content Type:

Video

In this episode of NAMSA’s MedTech Matters video series, Mark Boyle (Vice President of Global Consulting Services at NAMSA) discusses a key trend in the In Vitro Diagnostic (IVD) market–the movement towards molecular diagnostics, particularly over-the-counter and point-of-care diagnostics. He touches on the manufacturer considerations for products within this category, such as having a sound commercial plan in place, a good understanding of the market, and a good grasp of the current regulatory landscape, and how NAMSA can assist clients with this process.

Learn about how NAMSA’s IVD Consulting Services can accelerate your timelines.

Schedule a Consultation with our global experts.

*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com NAMSA uses a third-party provider, GoToWebinar, to host NAMSA webinars. For information related to GoToWebinar’s privacy policy and utilization of information, please contact GoToWebinar directly.